Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Catchpole

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Epidemics|September 11, 2022
The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemicMaria Piggin, Emma Smith, Peter Mankone, et al.
The Lancet. Microbe|June 12, 2023
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human studyJie Zhou, Anika Singanayagam, Niluka Goonawardane, et al.
NEJM Evidence|November 19, 2025
Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza VaccineKelly A Lindert, Alex Mann, Anita Geevarughese, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Effective Aerosol Inoculation of Dose-Escalated Seasonal Influenza H3N2 Virus in Controlled Human Infection ModelNadine Rouphael, Ralph Tanios, Jessica Traenkner, et al.
The Journal of Infectious Diseases|December 16, 2025
Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery SystemsNadine Rouphael, Ralph Tanios, Jessica Traenkner, et al.
Journal of Virology|October 7, 2025
Correction for Shetty et al., "Influenza virus infection and aerosol shedding kinetics in a controlled human infection model"Nishit Shetty, Meredith J Shephard, Nicole C Rockey, et al.
Ebiomedicine|November 14, 2021
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxisBrian M Maas, Jos Lommerse, Nele Plock, et al.
Nature Medicine|April 1, 2022
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adultsBen Killingley, Alex J Mann, Mariya Kalinova, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Epidemics|September 11, 2022
The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemicMaria Piggin, Emma Smith, Peter Mankone, et al.
The Lancet. Microbe|June 12, 2023
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human studyJie Zhou, Anika Singanayagam, Niluka Goonawardane, et al.
NEJM Evidence|November 19, 2025
Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza VaccineKelly A Lindert, Alex Mann, Anita Geevarughese, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Effective Aerosol Inoculation of Dose-Escalated Seasonal Influenza H3N2 Virus in Controlled Human Infection ModelNadine Rouphael, Ralph Tanios, Jessica Traenkner, et al.
The Journal of Infectious Diseases|December 16, 2025
Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery SystemsNadine Rouphael, Ralph Tanios, Jessica Traenkner, et al.
Journal of Virology|October 7, 2025
Correction for Shetty et al., "Influenza virus infection and aerosol shedding kinetics in a controlled human infection model"Nishit Shetty, Meredith J Shephard, Nicole C Rockey, et al.
Ebiomedicine|November 14, 2021
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxisBrian M Maas, Jos Lommerse, Nele Plock, et al.
Nature Medicine|April 1, 2022
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adultsBen Killingley, Alex J Mann, Mariya Kalinova, et al.
Pageof 3